Skip to main content

Table 2 Odds ratios and heterogeneity results in the meta-analysis of the association between MTHFR 677C>T polymorphism and cervical cancer

From: The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis

Contrast model

Studies (participants)

Fixed effects model

Random effects model

PH

I2 (%)

  

OR[95%CI]*

POR

OR[95%CI]

POR

  

Total studies#

       

TT versus CC

11(4,576)

1.05(0.85-1.30)

0.644

1.06(0.72-1.56)

0.773

0.008

58.2%

CT versus CC

11(4,576)

0.81(0.70-0.92)

0.002

0.86(0.67-1.11)

0.247

0.002

63.5%

TT + CT versus CC

11(4,576)

0.83(0.73-0.95)

0.005

0.90(0.68-1.20)

0.481

<0.001

73.3%

TT versus CT + CC

11(4,576)

1.14(0.94-1.38)

0.171

1.14(0.84-1.54)

0.412

0.052

45.1%

Caucasians

       

T versus C

6(2,769)

0.74(0.65-0.84)

<0.001

0.74(0.54-1.01)

0.056

0.004

71.0%

TT versus CC

6(2,769)

0.63(0.45-0.88)

0.007

0.64(0.45-0.89)

0.009

0.794

0.0%

CT versus CC

6(2,769)

0.69(0.58-0.82)

<0.001

0.74(0.50-1.09)

0.122

0.003

71.7%

TT + CT versus CC

6(2,769)

0.68(0.58-0.80)

<0.001

0.71(0.49-1.04)

0.082

0.003

72.8%

TT versus CT + CC

6(2,769)

0.73(0.52-1.01)

0.056

0.73(0.53-1.02)

0.067

0.871

0.0%

East Asians

       

T versus C

4(1,648)

1.24(1.07-1.44)

0.004

1.28(1.02-1.62)

0.034

0.092

53.5%

TT versus CC

4(1,648)

1.56(1.17-2.08)

0.003

1.66(1.05-2.62)

0.029

0.097

52.6%

CT versus CC

4(1,648)

1.08(0.85-1.37)

0.514

1.08(0.85-1.37)

0.518

0.754

0.0%

TT + CT versus CC

4(1,648)

1.20(0.96-1.50)

0.102

1.21(0.95-1.54)

0.120

0.340

10.6%

TT versus CT + CC

4(1,648)

1.51(1.17-1.94)

0.001

1.55(1.09-2.22)

0.016

0.157

42.4%

Europeans

       

T versus C

3(1,632)

0.77(0.66-0.89)

0.001

0.77(0.66-0.89)

0.001

0.828

0.0%

TT versus CC

3(1,632)

0.65(0.45-0.93)

0.020

0.65(0.45-0.93)

0.020

0.991

0.0%

CT versus CC

3(1,632)

0.71(0.58-0.88)

0.002

0.71(0.58-0.88)

0.002

0.552

0.0%

TT + CT versus CC

3(1,632)

0.70(0.58-0.86)

<0.001

0.70(0.58-0.86)

<0.001

0.658

0.0%

TT versus CT + CC

3(1,632)

0.75(0.53-1.07)

0.113

0.75(0.53-1.07)

0.113

0.922

0.0%

Indians§

       

TT versus CC

3(1,137)

0.51(0.20-1.30)

0.157

0.54(0.19-1.59)

0.260

0.321

12.0%

TT versus CT + CC

3(1,137)

0.57(0.22-1.46)

0.239

0.60(0.23-1.59)

0.305

0.471

0.0%

  1. (*OR = Odds Ratio; 95%CI = 95% Confidence Interval; † random = random-effects model; fixed = fixed-effects model; ‡PH, the P value of heterogeneity; # the data was not pooled in the analysis of the allele contrast model (T versus C) owing to the high heterogeneity (I2 = 79.8%); § the data was not pooled in the analyses of the allele contrast model (T versus C, I2 = 87.7%), heterozygote (CT versus CC, I2 = 87.8%), and dominant (TT and CT versus CC, I2 = 88.5%) models owing to the high heterogeneity.)